Literature DB >> 29314759

Reduced specificity of Erns antibody ELISAs for samples from piglets with maternally derived antibodies induced by vaccination of sows with classical swine fever marker vaccine CP7_E2alf.

D Meyer1, W Loeffen2, A Postel1, S Fritsche3, P Becher1.   

Abstract

Successful implementation of marker vaccines against classical swine fever virus is dependent on a reliable accompanying diagnostic assay that allows differentiation of infected from vaccinated animals (DIVA) as well as the development of a testing scheme during emergency vaccination. In this context, special attention needs to be paid to breeding farms, because the offspring of marker vaccinated sows possess maternally derived antibodies (MDAs). So far, limited information is available on the influence of MDAs on serological testing in the context of a DIVA strategy. Therefore, two commercially available Erns antibody ELISAs were compared, using serum samples of piglets with a high-to-moderate titre of MDAs against marker vaccine CP7_E2alf. False-positive results were detected by both Erns antibody ELISAs for serum samples of piglets with an age of up to 4 weeks. Interestingly, most samples tested false-positive in the first Erns antibody ELISA were identified correctly by the other Erns antibody ELISA and vice versa. In conclusion, in case of emergency vaccination of sows, the specificity of both ELISAs in newborn piglets younger than 4 weeks may be relatively low. This could be addressed in a testing strategy by either not sampling piglets up to the age of 4 weeks or using both ELISAs in a screening-confirmation set-up.
© 2018 Blackwell Verlag GmbH.

Entities:  

Keywords:  CP7_E2alf; DIVA assay; Erns antibody ELISA; classical swine fever virus; marker vaccine; maternally derived antibodies

Mesh:

Substances:

Year:  2018        PMID: 29314759     DOI: 10.1111/tbed.12795

Source DB:  PubMed          Journal:  Transbound Emerg Dis        ISSN: 1865-1674            Impact factor:   5.005


  5 in total

Review 1.  Research Progress and Challenges in Vaccine Development against Classical Swine Fever Virus.

Authors:  Qiang Wei; Yunchao Liu; Gaiping Zhang
Journal:  Viruses       Date:  2021-03-10       Impact factor: 5.048

Review 2.  The Development of Classical Swine Fever Marker Vaccines in Recent Years.

Authors:  Fangfang Li; Bingke Li; Xinni Niu; Wenxian Chen; Yuwan Li; Keke Wu; Xiaowen Li; Hongxing Ding; Mingqiu Zhao; Jinding Chen; Lin Yi
Journal:  Vaccines (Basel)       Date:  2022-04-13

3.  Characterization of the Humoral Immune Response Induced after Infection with Atypical Porcine Pestivirus (APPV).

Authors:  Gökce Nur Cagatay; Denise Meyer; Michael Wendt; Paul Becher; Alexander Postel
Journal:  Viruses       Date:  2019-09-21       Impact factor: 5.048

4.  The potential efficacy of the E2-subunit vaccine to protect pigs against different genotypes of classical swine fever virus circulating in Vietnam.

Authors:  Ha Thi Thanh Tran; Duc Anh Truong; Viet Duc Ly; Hao Thi Vu; Tuan Van Hoang; Chinh Thi Nguyen; Nhu Thi Chu; Vinh The Nguyen; Duyen Thuy Nguyen; Kohtaro Miyazawa; Takehiro Kokuho; Hoang Vu Dang
Journal:  Clin Exp Vaccine Res       Date:  2020-01-31

5.  Genetically distinct pestiviruses pave the way to improved classical swine fever marker vaccine candidates based on the chimeric pestivirus concept.

Authors:  Alexander Postel; Paul Becher
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.